Seelos Therapeutics, Inc. Income (Loss) from Continuing Operations, Per Basic Share
Seelos Therapeutics, Inc. reported Income (Loss) from Continuing Operations, Per Basic Share of -$0.44 per share for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2017-05-11
- Seelos Therapeutics, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2017-03-31 was -$0.44.
- Seelos Therapeutics, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2016-03-31 was -$0.46.
- Seelos Therapeutics, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2015-06-30 was -$0.10, a 433.33% decline year-over-year.
- Seelos Therapeutics, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2014-12-31 was -$0.40.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 6 month |
|---|---|---|
| 2017-03-31 | -$0.44 10-Q · filed 2017-05-11 | |
| 2016-03-31 | -$0.46 10-Q · filed 2017-05-11 | |
| 2015-06-30 | -$0.10 10-Q · filed 2015-08-05 | -$0.24 10-Q · filed 2015-08-05 |
| 2014-12-31 | -$0.40 10-K · filed 2016-03-09 | |
| 2014-09-30 | -$0.08 10-K · filed 2016-03-09 | |
| 2014-06-30 | $0.03 10-K · filed 2016-03-09 | -$0.06 10-Q · filed 2015-08-05 |
| 2014-03-31 | -$0.09 10-K · filed 2016-03-09 | |
| 2013-06-30 | -$0.12 10-Q · filed 2014-08-11 | -$0.35 10-Q · filed 2014-08-11 |